Sensitization of tumor cells to Apo2 ligand/TRAIL-induced apoptosis by inhibition of casein kinase II

Cancer Research

Volumn 62, Issue 15, 2002, Pages 4180-4185

  Ravi, Rajani ^a   Bedi, Atul ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APO2 LIGAND; CASEIN KINASE II; CASPASE 2; CASPASE 8; CASPASE 9; LIGAND; PROTEIN BAK; PROTEIN BAX; PROTEIN BCL XL; PROTEIN P53; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL PROTECTION; CELL SURVIVAL; CONTROLLED STUDY; DRUG DESIGN; ENZYME ACTIVATION; ENZYME INHIBITION; GENE ACTIVATION; GENE EXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; SIGNAL TRANSDUCTION; TUMOR CELL DESTRUCTION; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA; ANTINEOPLASTIC AGENTS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BCL-2-ASSOCIATED X PROTEIN; BCL-X PROTEIN; BH3 INTERACTING DOMAIN DEATH AGONIST PROTEIN; BREAST NEOPLASMS; CARRIER PROTEINS; CASEIN KINASE II; CASP8 AND FADD-LIKE APOPTOSIS REGULATING PROTEIN; COLONIC NEOPLASMS; DRUG SYNERGISM; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MEMBRANE GLYCOPROTEINS; NF-KAPPA B; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; RECOMBINANT PROTEINS; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0036682276     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Death receptors: Signaling and modulation
2. Safety and antitumor activity of recombinant soluble Apo2 ligand
3. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors
4. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis
5. Proapoptotic BAX and BAK: A requisite gateway to mitochondrial dysfunction and death
6. The Rel/NF-κB family directly activates expression of the apoptosis inhibitor Bcl-x(L)
7. Regulation of death receptor expression and TRAIL/Apo2L-induced apoptosis by NF-κB
8. BCL-2, BCL-X(L) sequester BH3 domain-only molecules preventing BAX- and BAK-mediated mitochondrial apoptosis
9. Protein kinase CK2 signal in neoplasia
10. Casein kinase II α transgene-induced murine lymphoma: Relation to theileriosis in cattle
11. Protein kinase CK2 in mammary gland tumorigenesis
12. Kinetics of inhibition by 5, 6-dichloro-1-β-D-ribofuranosylben-zimidazole on calf thymus casein kinase II
13. Casein kinase II is a selective target of HIV-1 transcriptional inhibitors
14. The replacement of ATP by the competitive inhibitor emodin induces conformational modifications in the catalytic site of protein kinase CK2
15. Disruption of p53 in human cancer cells alters the responses to therapeutic agents
16. Role of BAX in the apoptotic response to anticancer agents
17. Roles of IKK kinases and protein kinase CK2 in activation of nuclear factor-κB in breast cancer
18. Requirement of BAX for TRAIL/Apo2L-induced apoptosis of colorectal cancers: Synergism with sulindac-mediated inhibition of Bcl-x(L)
19. Constitutive phosphorylation of IκBα by casein kinase II occurs preferentially at serine 293: Requirement for degradation of free IκBα
20. Tumor necrosis factor α-induced phosphorylation of RelA/p65 on Ser529 is controlled by casein kinase II
21. NF-κB inducers upregulate cFLIP, a cycloheximide-sensitive inhibitor of death receptor signaling
22. Tumor-cell resistance to death receptor-induced apoptosis through mutational inactivation of the proapoptotic Bcl-2 homolog Bax
23. Phosphorylation of bid by casein kinases I and II regulates its cleavage by caspase 8
24. Regulation of p53 mediated transactivation by the β-subunit of protein kinase CK2
25. p53 deficiency and misexpression of protein kinase CK2α collaborate in the development of thymic lymphomas in mice